Clinical Trial Update: Her2-BATS and Pembrolizumab in Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating Her2-BATS in combination with pembrolizumab for metastatic breast cancer has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Her2-BATS
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: University of Virginia | Conditions: Metastatic Breast Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-02-27